Johnson & Johnson ($JNJ) isn't the only company with a hepatitis C drug operating in the shadow of new giants from Gilead Sciences ($GILD) and AbbVie ($ABBV). Merck & Co.'s Victrelis, a breakthrough product when it made its debut in…
GlaxoSmithKline ($GSK) is struggling to grow sales post-China bribery scandal, cutting jobs in the U.S. while focusing on a long-term overhaul to manufacturing and R&D to chart some upward momentum. The company was said to be exploring job cuts in…
Celgene's ($CELG) Abraxane is one of those cancer fighters that has proven effective against many forms of cancer, and so the company has sought approvals far and wide, sometimes successfully and other times not. Now it has been recommended in…
The World Health Organization says at least 8,153 people have died in the Ebola outbreak in West Africa. The Geneva-based body said Monday (01/05/2015) that the total number of confirmed, probable and suspected deaths from the disease comes from 20,656…
An American probe that will explore Pluto woke up from its slumber Saturday, after a nine-year journey to take a close look at the distant body for the first time. "New Horizons is healthy and cruising quietly through deep space,…
U.S. employment rose by 321,000 jobs last month, and the unemployment rate remained unchanged at 5.8 percent, the Labor Department said Friday. Economists polled by Thomson Reuters had expected net job growth of 230,000. The gain is over the average…
A top official with the U.N. health agency says few experimental therapies are currently under development that could effectively treat Ebola. Dr. Martin Friede, who is in charge of the World Health Organization's work toward finding an Ebola drug, says…